Back to catalogue
№ 127 33 filings · 2021-08-19 → 2026-09-09

CALNEX SOLUTIONS PLC

CLX
Telecommunications Share price 54.00p Market cap £48m Overall fit 560 /1000

Genuine hyperscaler/AI-infrastructure exposure with high operating leverage and strong downside protection, but current valuation does not obviously undervalue the business, FY27 is a deliberate investment plateau, and customer concentration is a real risk for a small-cap.

Fair value range 60p–90p Mid case · £66m
Absolute upside +38.8% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Clean IFRS disclosure with detailed segmental breakdowns
  • Simple business model amenable to normalised-earnings valuation
  • Fortress balance sheet eliminates financing risk
Limits the call
  • FY28 growth acceleration is central to the thesis and unproven
  • Customer concentration (22% of revenue from one customer) creates single-name risk
Methodology

Normalised EV/EBITDA and EV/Sales cross-check on FY28E mid-cycle earnings

In one line · bull case

Small-cap testing specialist with fortress balance sheet, high operating leverage, and genuine emerging AI-infrastructure exposure trading at a reasonable price ahead of a guided FY28 growth inflection.

In one line · biggest risk

Customer concentration (one hyperscaler = 22% of FY26 revenue) means a single procurement decision could materially move the numbers before the diversification thesis plays out.

Drivers
AI beneficiary 60 /100
Direct hyperscaler traction via Sentry data-centre sync and 400G AI network emulation; Nvidia/Meta among customers; but telecoms still 30% of orders.
Operating leverage 72 /100
Fixed R&D and central cost base with 76% gross margins; recent cycle shows 30-70% incremental margins in either direction.
Earnings vs expectations 55 /100
Mostly in-line delivery with one material FY24 downgrade during telecoms downturn.
Growth momentum 58 /100
FY26 revenue +19%; FY27 explicit plateau; FY28 acceleration guided but unproven.
Moat 55 /100
Specialised IP, long-term customer relationships, high switching costs once designed into test racks; no network effect.
Earnings quality 58 /100
Clean disclosure but capitalised R&D (£6.3m) large vs £1.2m PBT; RDEC accounting policy changed in FY26.
Management quality 65 /100
Founder-led since 2006, disciplined cost response in FY24, well-integrated iTrinegy acquisition.
Cyclicality 55 /100
Telecoms cyclicality proven in FY24; digital infrastructure diversification reduces but does not eliminate.
Leverage 5 /100
£11.2m net cash, no debt — fortress balance sheet.

CALNEX SOLUTIONS PLC (CLX) — Investment Research Note

Executive summary

Calnex designs test-and-measurement instrumentation validating high-performance network synchronisation and network emulation for telecoms operators, hyperscalers, and government/defence customers (blue-chip roster including Nvidia, Meta, Ericsson, Nokia, Intel, NTT). Over the 5-year window the business rode a 5G capex peak in FY23 (£27.4m rev, £7.2m PBT), suffered a sharp telecoms-driven downturn in FY24 (£16.3m rev, small loss), and has since re-based around a more diversified end-market mix — telecoms fell to 30% of orders in FY26 while digital infrastructure (hyperscalers/data centres) reached 49% and government & defence 21% 2026-05 FY26 final. The single most important valuation point today: the stock trades at £53m for a company with £11m net cash, 76% gross margins, and increasing exposure to AI-driven hyperscaler timing/network emulation demand — but FY27 is an explicit investment year with the growth inflection deliberately pushed into FY28.

Fair value estimate

Range: 60p – 90p per share (£53m – £79m market cap), mid ~75p (£66m).

Methodology: blended multiple-of-forward-earnings + EV/sales cross-check, anchored to a normalised through-cycle earnings estimate rather than depressed FY26 numbers.

  • FY26 revenue £21.9m, Underlying EBITDA £1.8m (adjusted for R&D amortisation) 2026-05 FY26 final. Peak FY23 was £27.4m revenue / £8.0m Underlying EBITDA.
  • Assuming FY28 recovery to £26-30m revenue with EBITDA margins re-inflating to 15-25% (mid-cycle historical range), gives normalised EBITDA of £4-6m. Applying 10-14x EV/EBITDA + £11m net cash = £51m-£95m EV range → market cap £62m-£106m.
  • Cross-check on EV/Sales: current EV ~£42m / FY26 revenue £21.9m = ~1.9x. Sector peers (Spirent pre-acquisition, Viavi) typically trade 2-3x through cycle. Applied to FY28E ~£25m revenue → EV £50-75m.

Vs. current £52.8m cap: midpoint implies ~24% upside; downside ~1% (view: fair-to-slightly undervalued).

Sector context

Confirmed classification: Telecommunications / Test & Measurement equipment. Calnex's quality profile (net cash, 76% gross margins, 79% repeat orders, capital-light, no direct debt) is above typical telecoms-hardware peers, though its scale (£22m rev) is small. Growth profile currently sub-par vs. software peers but has structural AI/data-centre tailwind emerging. Listed peers: Viavi Solutions (partner, larger US-listed comp), Keysight Technologies (much larger US comp), Spirent Communications (recently acquired — its distribution relationship with Calnex was terminated in 2024, effectively freeing Calnex to build its own channel).

Investment thesis (3 bullets)

  • Direct hyperscaler / AI-infrastructure exposure is building beyond marketing language. FY26 saw a "significant repeat Sentry order from a leading hyperscaler" for data-centre sync monitoring; digital infrastructure is now 49% of orders (FY25: 49%, FY23: 34%). Post-period Calnex demonstrated a 400G network emulation for AI congestion testing, and the Sentry, SNE emulation, and 1.6Tb/s sync roadmap are aimed squarely at AI-training network validation 2026-05 FY26 final; 2026-09 CMD.
  • High operating leverage against a fixed cost base offers asymmetric upside if FY28 growth materialises. Revenue swung from £27m→£16m→£22m over three years while operating profit went £7.2m→(£0.6m)→£1.0m — a 65-70% incremental drop-through. If FY28 acceleration delivers £25-30m revenue, PBT plausibly returns to £4-6m 2026-05 FY26 final.
  • Fortress balance sheet + strong customer economics reduce downside. £9.3m period-end cash (£11.2m weeks later), no debt, dividends maintained through the downturn, 20-year operating history, 79% repeat-order rate, and customer base including Nvidia, Meta, Intel, BT — this is not a fragile business 2026-05 FY26 final.

Key risks (3 bullets)

  • Customer concentration is meaningful and increasing. In FY26, one customer accounted for 22% of revenue and 25% of orders (FY25: 17%); top-10 rose to 55% of orders on 3-yr average (FY25: 45%) 2026-05 FY26 final. A single hyperscaler pushing out orders would materially move the P&L.
  • FY27 is an investment year with deliberately deferred payoff. Management is explicitly increasing R&D and go-to-market spend in FY27 while targeting the step-change in FY28. If growth doesn't materialise, margins remain depressed on a higher cost base 2026-05 FY26 final; 2026-09 AGM.
  • Capitalised R&D is large relative to profits, blurring earnings quality. FY26 capitalised R&D was £6.3m (vs £4.6m amortisation, £1.2m PBT). The gap means underlying cash burn on R&D exceeds the P&L charge, and reported profits are flattered by capitalisation policy 2026-05 FY26 final.

Operating leverage

Calnex has high operating leverage — the historical financials give a clean illustration. From FY23→FY24 revenue fell £11.2m and underlying EBITDA fell £7.9m, implying a ~70% incremental margin. Reverse: FY24→FY26 revenue rose £5.6m and underlying EBITDA rose £1.7m (~30% — lower because of planned investment in sales/marketing headcount). Gross margins are structurally 75-76% 2026-05 FY26 final. Fixed cost base includes ~163 headcount (80 in R&D), capitalised R&D pipeline, and lease overheads — none scales linearly with revenue. Consequence: if FY28 revenue grows 15-20% above FY27 (implicit management guide), operating profit plausibly doubles or triples off the low FY26 base. Not a doubling of the whole business, but of profit. The user-relevant "long-tail" characteristic is genuinely present.

Value-trap signals

None identified. The FY24 drawdown was a well-documented telecoms industry cycle rather than a company-specific problem, revenue and orders have recovered, dividend maintained, no debt, customer base intact and diversifying, no restatements or auditor emphasis-of-matter. The only genuine watch item is capitalised R&D vs cash earnings, which is normal for a hardware-development business and not out of line with peers.

Earnings vs. expectations

Across the 5-year window Calnex has generally delivered in line with or slightly ahead of consensus, with one material miss: in October 2023 the company issued a trading update warning FY24 revenues would be 20-30% below market expectations due to telecoms customer spending delays — a clear miss driving the FY24 loss 2023-10 trading update. Otherwise: FY22 slightly ahead, FY23 in line, FY25 in line with post-downgrade expectations, FY26 "slightly ahead of market expectations" 2026-05 FY26 final, and FY27-to-date "in line" per the September 2026 AGM statement. Pattern: mostly in-line delivery, but with a demonstrated willingness to guide down when the cycle turns — not a serial disappointer, but not a stock that consistently exceeds either.

Conviction

3 — moderate. Anchors: (i) clean IFRS-compliant disclosure with detailed segmental and product-line breakdowns, (ii) simple business model that lends itself to normalised-earnings valuation, (iii) balance sheet strength eliminates financing risk. Caveats: (i) FY28 growth acceleration is the crux of the bull case and remains unproven — the range of outcomes at £22m vs £30m revenue is material for a small-cap, (ii) customer concentration means a single hyperscaler decision can move numbers meaningfully.

Driver scoring rationale

  • AI beneficiary (60): genuine hyperscaler traction — repeat Sentry order, 400G AI emulation capability, 1.6Tb/s sync in development, Nvidia/Meta customers — but still 30% of orders are legacy telecoms and AI-specific revenue is not yet dominant.
  • Operating leverage (72): high fixed cost base, 76% gross margins, small scale — recent history demonstrates ~30-70% incremental margins in either direction.
  • Earnings surprise trend (55): mostly in-line with one FY24 miss/guidance cut.
  • Cyclicality (55): telecoms testing is moderately cyclical (proven in FY24); digital infrastructure diversification reduces but does not eliminate.
  • Moat (55): specialised technical IP, deep long-term customer relationships (10-yr average with top 10), high switching costs once designed into test racks, but not dominant network effects.
  • Leverage (5): net cash of £11.2m, no debt, fortress balance sheet.
  • Earnings quality (58): clean disclosure but heavy capitalised R&D relative to profit; policy change on RDEC accounting in FY26 reduces comparability.
  • Management quality (65): founder-led (Tommy Cook since 2006), consistent execution, disciplined cost response in FY24, sensible small acquisition of iTrinegy 2022 that appears well-integrated.
  • Growth momentum (58): FY26 +19% revenue growth is healthy; FY27 explicitly a plateau; FY28 acceleration guided.

Overall score rationale

Score 560/1000: solid fit for the AI-receiver strategy with genuine (not press-release) hyperscaler exposure, real operating leverage against a fixed cost base, and strong downside protection from the balance sheet — but current market cap doesn't obviously undervalue the business, FY27 is a stated investment year, and customer concentration is a real risk for a small-cap. Not a screaming buy, but a legitimate portfolio candidate at current levels with meaningful upside if FY28 delivers.

Filings consulted · 45

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-09Capital Markets Day2026-09-09_9761963_capital-markets-day.md0.95
  2. 2026-09-02Result OF Agm2026-09-02_9752691_result-of-agm.md0.30
  3. 2026-09-02Agm Statement2026-09-02_9750353_agm-statement.md0.40
  4. 2026-07-22Notice OF Agm And Posting OF Annual Report2026-07-22_9682098_notice-of-agm-and-posting-of-annual-report.md0.95
  5. 2026-05-26Final Results2026-05-26_9583855_final-results.md1.00
  6. 2026-04-13Fy26 Trading Update And Notice OF Results2026-04-13_9515694_fy26-trading-update-and-notice-of-results.md0.85
  7. 2025-11-18Interim Results2025-11-18_9239850_interim-results.md0.77
  8. 2025-08-14Result OF Agm2025-08-14_9054132_result-of-agm.md0.20
  9. 2025-08-14Agm Statement2025-08-14_9051803_agm-statement.md0.26
  10. 2025-07-15Notice OF Agm And Posting OF Annual Report2025-07-15_8979098_notice-of-agm-and-posting-of-annual-report.md0.62
  11. 2025-05-20Final Results2025-05-20_8886259_final-results.md0.65
  12. 2025-05-15Notice OF Investor Presentation2025-05-15_8879078_notice-of-investor-presentation.md0.46
  13. 2025-04-08Fy25 Trading Update And Notice OF Results2025-04-08_8818396_fy25-trading-update-and-notice-of-results.md0.55
  14. 2024-11-19Interim Results2024-11-19_8557986_interim-results.md0.58
  15. 2024-11-04Notice OF Results And Investor Presentation2024-11-04_8526687_notice-of-results-and-investor-presentation.md0.46
  16. 2024-08-22Result OF Agm2024-08-22_8380865_result-of-agm.md0.14
  17. 2024-08-22Agm Statement2024-08-22_8378772_agm-statement.md0.18
  18. 2024-07-18Notice OF Agm2024-07-18_8318539_notice-of-agm.md0.14
  19. 2024-07-18Notice OF Agm2024-07-18_8318536_notice-of-agm.md0.14
  20. 2024-05-21Fy24 Final Results2024-05-21_8209892_fy24-final-results.md0.45
  21. 2024-04-10Notice OF Investor Presentation2024-04-10_8129362_notice-of-investor-presentation.md0.32
  22. 2024-04-03Fy24 Trading Update And Notice OF Results2024-04-03_8117302_fy24-trading-update-and-notice-of-results.md0.38
  23. 2023-11-21Interim Results2023-11-21_7893112_interim-results.md0.41
  24. 2023-10-26Notice OF Investor Presentation2023-10-26_7839919_notice-of-investor-presentation.md0.32
  25. 2023-10-10Trading Update And Notice OF Results2023-10-10_7807994_trading-update-and-notice-of-results.md0.38
  26. 2023-08-16Result OF Agm2023-08-16_7699945_result-of-agm.md0.07
  27. 2023-08-16Agm Statement2023-08-16_7698295_agm-statement.md0.10
  28. 2023-07-17Notice OF Agm2023-07-17_7635647_notice-of-agm.md0.07
  29. 2023-05-23Fy23 Final Results2023-05-23_7538099_fy23-final-results.md0.25
  30. 2023-05-04Notice OF Results And Investor Presentation2023-05-04_7511987_notice-of-results-and-investor-presentation.md0.17
  31. 2023-03-07Trading Update2023-03-07_7325644_trading-update.md0.21
  32. 2022-11-22Interim Results2022-11-22_7454081_interim-results.md0.23
  33. 2022-10-27Notice OF Results And Investor Presentation2022-10-27_7160891_notice-of-results-and-investor-presentation.md0.17
  34. 2022-08-17Result OF Agm2022-08-17_7129590_result-of-agm.md0.07
  35. 2022-08-17Agm Statement2022-08-17_7127685_agm-statement.md0.10
  36. 2022-07-18Notice OF Agm2022-07-18_7034845_notice-of-agm.md0.07
  37. 2022-05-24Fy22 Final Results2022-05-24_6975160_fy22-final-results.md0.25
  38. 2022-05-06Notice OF Investor Presentation2022-05-06_7195016_notice-of-investor-presentation.md0.17
  39. 2022-04-12Acquisition OF Itrinegy And Update ON Trading2022-04-12_6941870_acquisition-of-itrinegy-and-update-on-trading.md0.19
  40. 2022-03-01Trading Update2022-03-01_6962203_trading-update.md0.21
  41. 2021-11-23Interim Results2021-11-23_6837521_interim-results.md0.23
  42. 2021-11-10Notice OF Results And Investor Presentation2021-11-10_6690733_notice-of-results-and-investor-presentation.md0.17
  43. 2021-10-12Trading Update2021-10-12_6762858_trading-update.md0.21
  44. 2021-08-19Result OF Agm2021-08-19_6600177_result-of-agm.md0.03
  45. 2021-08-19Agm Statement2021-08-19_6597238_agm-statement.md0.04

This research note was authored by a large language model after reading 33 regulatory filings published between 2021-08-19 and 2026-09-09. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.